Biography

Johanna Kuhlin is an infectious diseases physician working at Karolinska University Hospital in Stockholm, Sweden and is affiliated with Karolinska Institutet, Sweden. Johanna finished her PhD in 2023 on treatment on drug-resistant tuberculosis and has conducted a PostDoc at University of Cape Town, South Africa, between 2023 and 2025. Her research includes studies from Uzbekistan, China, Sweden and South Africa on treatment of drug-resistant and drug-susceptible TB, pharmacokinetics and drug-resistance.

Expertise

TB Diagnostics
Public Health

Key Impacts

Treatment outcomes of bedaquiline-resistant TB: A retrospective and matched cohort study

Current treatment options for bedaquiline-resistant TB result in prolonged therapy, delayed microbiological responses, and poor clinical outcomes.

Source: Conference 2024

Research Summaries

PAPER
Bedaquiline resistance delays recovery and raises failure in RR-TB
22 Jan 2025